表观遗传年龄模型捕捉胶质瘤DNA甲基化模式与分子亚型、生存及复发的关系
研究利用Horvath时钟和epiTOC两种表观遗传年龄模型,在516例低级别胶质瘤、141例胶质母细胞瘤及136例正常脑样本中分析表观遗传年龄与WHO分级、分子亚型、生存和复发的关系,并在203例胶质瘤独立队列中验证。胶质瘤表观遗传年龄普遍加速,两种模型高度相关且呈现反映分子亚型的独特模式,epiTOC是生存的显著独立预测因子,原发与复发肿瘤间表观遗传年龄差异高度可变且与复发时间无显著关联。
要点
- 胶质瘤表观遗传年龄较正常组织近乎普遍加速。
- Horvath时钟与epiTOC高度相关,呈现反映分子亚型的独特老化模式。
- epiTOC是胶质瘤生存的显著独立预测因子。
核心结论
- 表观遗传老化反映表观基因组的连贯修饰,可能为胶质瘤提供额外预后价值。
研究设计与样本
- 使用Horvath时钟和epiTOC计算516例低级别胶质瘤、141例胶质母细胞瘤及136例非肿瘤正常脑样本的表观遗传年龄。
- 在203例胶质瘤独立队列中验证表观遗传年龄与诊断时实际年龄的关联。
- 采用Cox比例风险模型评估表观遗传年龄对生存预测的贡献。
- 分析18例患者共63个原发-复发胶质瘤配对样本的表观遗传年龄差异及老化速率与复发时间的关系。
主要发现
- 与正常组织相比,胶质瘤表观遗传年龄使用Horvath时钟和epiTOC均近乎普遍加速。
- 两种独立表观遗传老化模型高度相关,并呈现反映分子亚型的独特老化模式。
- epiTOC是生存的显著独立预测因子。
- 原发与复发肿瘤间的表观遗传老化高度可变,与复发时间无显著关联。
局限性
- 原发与复发肿瘤间的表观遗传老化高度可变,且与复发时间无显著关联。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Models of epigenetic aging (epigenetic clocks) have been implicated as potentially useful markers for cancer risk and prognosis. Using 2 previously published methods for modeling epigenetic age, Horvath's clock and epiTOC, we investigated epigenetic aging patterns related to World Health Organization grade and molecular subtype as well as associations of epigenetic aging with glioma survival and recurrence. METHODS: Epigenetic ages were calculated using Horvath's clock and epiTOC on 516 lower-grade glioma and 141 glioblastoma cases along with 136 nontumor (normal) brain samples. Associations of tumor epigenetic age with patient chronological age at diagnosis were assessed with correlation and linear regression, and associations were validated in an independent cohort of 203 gliomas. Contribution of epigenetic age to survival prediction was assessed using Cox proportional hazards modeling. Sixty-three samples from 18 patients with primary-recurrent glioma pairs were also analyzed and epigenetic age difference and rate of epigenetic aging of primary-recurrent tumors were correlated to time to recurrence. RESULTS: Epigenetic ages of gliomas were near-universally accelerated using both Horvath's clock and epiTOC compared with normal tissue. The 2 independent models of epigenetic aging were highly associated with each other and exhibited distinct aging patterns reflective of molecular subtype. EpiTOC was found to be a significant independent predictor of survival. Epigenetic aging of gliomas between primary and recurrent tumors was found to be highly variable and not significantly associated with time to recurrence. CONCLUSIONS: We demonstrate that epigenetic aging reflects coherent modifications of the epigenome and can potentially provide additional prognostic power for gliomas.
引用
- Liao P, Ostrom QT, Stetson L, et al. Models of epigenetic age capture patterns of DNA methylation in glioma associated with molecular subtype, survival, and recurrence. Neuro Oncol. 2018. PMID: 29432558. doi:10.1093/neuonc/noy003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。